Literature DB >> 16809328

Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.

A J Frater1, C T T Edwards, N McCarthy, J Fox, H Brown, A Milicic, N Mackie, T Pillay, J W Drijfhout, S Dustan, J R Clarke, E C Holmes, H T Zhang, K Pfafferott, P J Goulder, M O McClure, J Weber, R E Phillips, S Fidler.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) genetic diversity is a major obstacle for the design of a successful vaccine. Certain viral polymorphisms encode human leukocyte antigen (HLA)-associated immune escape, potentially overcoming limited vaccine protection. Although transmission of immune escape variants has been reported, the overall extent to which this phenomenon occurs in populations and the degree to which it contributes to HIV-1 viral evolution are unknown. Selection on the HIV-1 env gene at transmission favors neutralization-sensitive variants, but it is not known to what degree selection acts on the internal HIV-1 proteins to restrict or enhance the transmission of immune escape variants. Studies have suggested that HLA class I may determine susceptibility to HIV-1 infection, but a definitive role for HLA at transmission remains unproven. Comparing populations of acute seroconverters and chronically infected patients, we found no evidence of selection acting to restrict transmission of HIV-1 variants. We found that statistical associations previously reported in chronic infection between viral polymorphisms and HLA class I alleles are not present in acute infection, suggesting that the majority of viral polymorphisms in these patients are the result of transmission rather than de novo adaptation. Using four episodes of HIV-1 transmission in which the donors and recipients were both sampled very close to the time of infection we found that, despite a transmission bottleneck, genetic variants of HIV-1 infection are transmitted in a frequency-dependent manner. As HIV-1 infections are seeded by unique donor-adapted viral variants, each episode is a highly individual antigenic challenge. Host-specific, idiosyncratic HIV-1 antigenic diversity will seriously tax the efficacy of immunization based on consensus sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809328      PMCID: PMC1489048          DOI: 10.1128/JVI.02014-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

2.  Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.

Authors:  Jan H Kessler; Bregje Mommaas; Tuna Mutis; Ivo Huijbers; Debby Vissers; Willemien E Benckhuijsen; Geziena M Th Schreuder; Rienk Offringa; Els Goulmy; Cornelis J M Melief; Sjoerd H van der Burg; Jan W Drijfhout
Journal:  Hum Immunol       Date:  2003-02       Impact factor: 2.850

3.  Genetic risk factors for perinatally acquired HIV-1 infection.

Authors:  J Just; L Louie; E Abrams; S W Nicholas; D Wara; Z Stein; M C King
Journal:  Paediatr Perinat Epidemiol       Date:  1992-04       Impact factor: 3.980

4.  Evolution and transmission of stable CTL escape mutations in HIV infection.

Authors:  P J Goulder; C Brander; Y Tang; C Tremblay; R A Colbert; M M Addo; E S Rosenberg; T Nguyen; R Allen; A Trocha; M Altfeld; S He; M Bunce; R Funkhouser; S I Pelton; S K Burchett; K McIntosh; B T Korber; B D Walker
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

5.  Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates.

Authors:  R B Oelrichs; V A Lawson; K M Coates; C Chatfield; N J Deacon; D A McPhee
Journal:  J Biomed Sci       Date:  2000 Mar-Apr       Impact factor: 8.410

6.  Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Authors:  Andrew J Leigh Brown; Simon D W Frost; W Christopher Mathews; Keith Dawson; Nicholas S Hellmann; Eric S Daar; Douglas D Richman; Susan J Little
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

7.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Authors:  S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

8.  A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

Authors:  Catherine Fagard; Annette Oxenius; Huldrych Günthard; Felipe Garcia; Michelle Le Braz; Gabriel Mestre; Manuel Battegay; Hansjakob Furrer; Pietro Vernazza; Enos Bernasconi; Amalio Telenti; Rainer Weber; Dominique Leduc; Sabine Yerly; David Price; Sara J Dawson; Thomas Klimkait; Thomas V Perneger; Angela McLean; Bonaventura Clotet; Jose M Gatell; Luc Perrin; Montserrat Plana; Rodney Phillips; Bernard Hirschel
Journal:  Arch Intern Med       Date:  2003-05-26

9.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen Sarkis; Ayub Ali; Jason D Harlow; Christian Brander; Spyros A Kalams; Bruce D Walker
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307

View more
  15 in total

1.  Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Authors:  Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Hiroshi Mohri; Rudolf Bohm; Mohammed Saifuddin; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-01-29       Impact factor: 3.616

2.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

3.  [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].

Authors:  Hong-Miao Liu; Ning-Ning Ma; Chun Luo; Shu-Ying Yuan; Fu-Li Liu; Xin-Gang Yao; Chun-Qiong Zhou; Min Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

4.  Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.

Authors:  C M Noviello; S L Kosakovsky Pond; M J Lewis; D D Richman; S K Pillai; O O Yang; S J Little; D M Smith; J C Guatelli
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo.

Authors:  Janka Petravic; Liyen Loh; Stephen J Kent; Miles P Davenport
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

6.  HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.

Authors:  A Duda; L Lee-Turner; J Fox; N Robinson; S Dustan; S Kaye; H Fryer; M Carrington; M McClure; A R McLean; S Fidler; J Weber; R E Phillips; A J Frater
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.

Authors:  A J Frater; H Brown; A Oxenius; H F Günthard; B Hirschel; N Robinson; A J Leslie; R Payne; H Crawford; A Prendergast; C Brander; P Kiepiela; B D Walker; P J R Goulder; A McLean; R E Phillips
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

8.  HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.

Authors:  Jonathan M Carlson; Malinda Schaefer; Daniela C Monaco; Rebecca Batorsky; Daniel T Claiborne; Jessica Prince; Martin J Deymier; Zachary S Ende; Nichole R Klatt; Charles E DeZiel; Tien-Ho Lin; Jian Peng; Aaron M Seese; Roger Shapiro; John Frater; Thumbi Ndung'u; Jianming Tang; Paul Goepfert; Jill Gilmour; Matt A Price; William Kilembe; David Heckerman; Philip J R Goulder; Todd M Allen; Susan Allen; Eric Hunter
Journal:  Science       Date:  2014-07-10       Impact factor: 47.728

9.  Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes.

Authors:  Duncan Palmer; John Frater; Rodney Phillips; Angela R McLean; Gil McVean
Journal:  Proc Biol Sci       Date:  2013-05-15       Impact factor: 5.349

10.  Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy.

Authors:  Genevieve E Martin; Debattama R Sen; Matthew Pace; Nicola Robinson; Jodi Meyerowitz; Emily Adland; John P Thornhill; Mathew Jones; Ane Ogbe; Lucia Parolini; Natalia Olejniczak; Panagiota Zacharopoulou; Helen Brown; Christian B Willberg; Nneka Nwokolo; Julie Fox; Sarah Fidler; W Nicholas Haining; John Frater
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.